Cytrx Corporation Announces That FDA Has Removed Partial Clinical Hold For Cancer Drug By: TalkMarkets January 20, 2015 at 11:55 AM EST Trials currently in phase 2 testing Aldoxorubicin in cancer patients have a partial clinical hold lifted. Read More >>